Data Emerge on New Immunotherapeutic Targets for Melanoma

Excerpt:

“Several trials either have been completed or are underway to evaluate new immunotherapeutic targets for patients with melanoma, according to a presenter at HemOnc Today New York.

” ‘When we think about where we’re going with immune therapy, it’s important to realize where we are and where have we been,’ Michael A. Postow, MD, assistant attending physician on the melanoma-sarcoma service at Memorial Sloan Kettering Cancer Center, said during his presentation. ‘What are the targets we have been using, and how do we modify what we know and explore totally new territory to try to improve outcomes?’ ”

Go to full article.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to use our ASK Cancer Commons service.